JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110771200 on November 27, 2001

J. Biol. Chem., Vol. 277, Issue 6, 4455-4464, February 8, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/6/4455    most recent
M110771200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, S.
Right arrow Articles by Gill, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, S.
Right arrow Articles by Gill, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

GC Box-binding Transcription Factors Control the Neuronal Specific Transcription of the Cyclin-dependent Kinase 5 Regulator p35*

Sarah RossDagger §, Anri TienhaaraDagger §, Ming-Sum LeeDagger ||**, Li-Huei TsaiDagger ||**, and Grace GillDagger Dagger Dagger

From the Dagger  Department of Pathology and || Howard Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115

Cyclin-dependent kinase 5 (cdk5)/p35 kinase activity is highest in post-mitotic neurons of the central nervous system and is critical for development and function of the brain. The neuronal specific activity of the cdk5/p35 kinase is achieved through the regulated expression of p35 mRNA. We have identified a small 200-bp fragment of the p35 promoter that is sufficient for high levels of neuronal specific expression. Mutational analysis of this TATA-less promoter has identified a 17-bp GC-rich element, present twice, that is both required for promoter activity and sufficient for neuronal specific transcription. A GC box within the 17-bp element is critical for both promoter activity and protein-DNA complex formation. The related transcription factors Sp1, Sp3, and Sp4 constitute most of the GC box DNA binding activity in neurons. We have found that both the relative contribution of the Sp family proteins to GC box binding and the transcriptional activity of these proteins is regulated during neuronal differentiation. Thus, our data show that the GC box-binding Sp proteins contribute to the regulation of p35 expression in neurons, suggesting changes in the Sp transcription factors level and activity may contribute to cell type-specific expression of many genes in the central nervous system.


* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by a Taplin research fellowship.

Current address: Center for Laboratory Medicine, Tampere University Hospital, P. O. Box 2000, FIN-33521 Tampere, Finland.

** Supported in part National Institutes of Health Grant RO1 GM53049 (to L.-H. T.).

Dagger Dagger To whom correspondence should be addressed: Dept. of Pathology, Harvard Medical School, 200 Longwood Ave., Boston, MA 02115. Tel.: 617-432-0985; Fax: 617-432-1313; E-mail: grace_gill@hms.harvard.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J.-H. Lee, M.-W. Jeong, W. Kim, Y. H. Choi, and K.-T. Kim
Cooperative Roles of c-Abl and Cdk5 in Regulation of p53 in Response to Oxidative Stress
J. Biol. Chem., July 11, 2008; 283(28): 19826 - 19835.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Ramos, B. Gaudilliere, A. Bonni, and G. Gill
Transcription factor Sp4 regulates dendritic patterning during cerebellar maturation
PNAS, June 5, 2007; 104(23): 9882 - 9887.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. Wang, X. Qi, W. Wei, E. W. Englander, and G. H. Greeley Jr.
Characterization of the 5'-regulatory regions of the rat and human apelin genes and regulation of breast apelin by USF
FASEB J, December 1, 2006; 20(14): 2639 - 2641.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Y. Chang, P. Ostling, M. Akerfelt, D. Trouillet, M. Rallu, Y. Gitton, R. El Fatimy, V. Fardeau, S. Le Crom, M. Morange, et al.
Role of heat-shock factor 2 in cerebral cortex formation and as a regulatorof p35 expression.
Genes & Dev., April 1, 2006; 20(7): 836 - 847.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Chen, Q. Wang, X. Wang, and G. P. Studzinski
Up-Regulation of Egr1 by 1,25-Dihydroxyvitamin D3 Contributes to Increased Expression of p35 Activator of Cyclin-Dependent Kinase 5 and Consequent Onset of the Terminal Phase of HL60 Cell Differentiation
Cancer Res., August 1, 2004; 64(15): 5425 - 5433.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. L. Parham, S. Zervou, E. Karteris, R. D. Catalano, R. W. Old, and E. W. Hillhouse
Promoter Analysis of Human Corticotropin-Releasing Factor (CRF) Type 1 Receptor and Regulation by CRF and Urocortin
Endocrinology, August 1, 2004; 145(8): 3971 - 3983.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.